The fact that this news is published in a specialized media such as “Estrategia Empresarial” reinforces the position of VIVEbiotech as a manufacturer of lentiviral vectors in the international market. It also allows the dissemination to a more general public of the Gene Therapy field and of the development of innovative technologies such as LENTISOMA.
Publicado el 22 enero 2018
Publication of VIVEbiotech in “Estrategia Empresarial”
The biweekly newspaper “Estrategia Empresarial” has published a new on its Inno-Tech section on the occasion of the visit of the Health Minister of the Basque Government, Jon Darpón, the Deputy Minister of Health, Iñaki Berraondo, and the Director of Health Research and Innovation, María Aguirre as we were able to report last week.